IMPORTANT SAFETY INFORMATION: NexGard is for use in dogs only. The most frequently reported adverse reactions included pruritus, vomiting, dry/ﬂaky skin, diarrhea, lethargy, and lack of appetite. The safe use of NexGard in pregnant, breeding, or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures. For additional information, CLICK HERE for full prescribing information or visit www.NexGardForDogs.com.
IMPORTANT RISK INFORMATION: HEARTGARD® Plus (ivermectin/pyrantel) is well tolerated. All dogs should be tested for heartworm infection before starting a preventive program. Following the use of HEARTGARD Plus, digestive and neurological side effects have rarely been reported. For additional information, CLICK HERE for full prescribing information or please visit www.HEARTGARD.com.
IMPORTANT SAFETY INFORMATION: PREVICOX® (firocoxib) is for use in dogs only. As a class, cyclooxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney or liver side effects. These are usually mild, but may be serious. Pet owners should discontinue therapy and contact their veterinarian immediately if side effects occur. Evaluation for pre-existing conditions and regular monitoring are recommended for pets on any medication, including PREVICOX. Use with other NSAIDs, corticosteroids or nephrotoxic medication should be avoided. For additional information, CLICK HERE for full prescribing information or visit www.PREVICOX.com.
IMPORTANT SAFETY INFORMATION:
METACAM (meloxicam oral suspension) is for use in dogs only. Repeated use of
meloxicam in cats has been associated with acute renal failure and death. Do not administer additional injectable or oral
meloxicam to cats. As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side
effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but
may be serious. If side effects occur, dog owners should halt therapy and contact their veterinarian. Dogs should be evaluated for
pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on
therapy. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided or monitored closely.
The safe use of METACAM in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating bitches has
not been evaluated. Please CLICK HERE for complete product information or visit www.metacam.com.
IMPORTANT SAFETY INFORMATION: CENTRAGARD® (eprinomectin and praziquantel transdermal solution) is for topical use only. Side effects may include emesis, anorexia, lethargy, and hair changes and skin reactions at the site of application. If ingested, hypersalivation, vomiting and lethargy may be observed. The safety of CENTRAGARD has not been tested in kittens less than 7 weeks of age or less than 1.8 lbs. CLICK HERE for full prescribing information.